VANDA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF NEREUS™ (TRADIPITANT) FOR THE PREVENTION OF VOMITING INDUCED BY MOTION: A HISTORIC SCIENTIFIC MILESTONE IN THE PREVENTION OF MOTION SICKNESS

Reuters · 12/30/2025 23:13

Please log in to view news